[1]
G.D. Dangas, B.E. Claessen, A. Caixeta, E.A. Sanidas, et al. In-Stent Restenosis in the Drug-Eluting Stent Era, J Am Coll Cardiol. 56(2010)1897-(1907).
DOI: 10.1016/j.jacc.2010.07.028
Google Scholar
[2]
F. Witte, H. Ulrich, M. Rudert, E. Willbold, Biodegradable magnesium scaffolds, Part I. Appropriate inflammatory response, J Biomed Mater Res A. 81(2007) 748-765.
DOI: 10.1002/jbm.a.31170
Google Scholar
[3]
S.Y. Cho, S.W. Chae, K.W. Choi, H.K. Seok, et al. Biocompatibility and strength retention of biodegradable Mg-Ca-Zn alloy bone implants, J Biomed Mater Res Part B: Appl Biomater 00B(2012)1-12.
DOI: 10.1002/jbm.b.32813
Google Scholar
[4]
A. Drynda, N. Deinet, N. Braun, M. Peuster, Rare earth metals used in biodegradable magnesium- based stents do not interfere with proliferation of smooth muscle cells but do induce the upregulation of inflammatory genes, J Biomed Mater Res A. 91(2009).
DOI: 10.1002/jbm.a.32235
Google Scholar
[5]
R. Erbel, C.D. Mario, J. Bartunek, J. Bonnier, et al. Temporary scaffolding of coronary arteries with bioabsorbable magnesium stents: a prospective, non-randomised multicentre trial. Lancet 369(2007) 1869-1875.
DOI: 10.1016/s0140-6736(07)60853-8
Google Scholar
[6]
R. Waksman, R. Pakala, P.K. Kuchulakanti, R. Baffour, et al. Safety and efficacy of bioabsorbable magnesium alloy stents in porcine coronary arteries, Catheter Cardiovasc Interven. 68(2006)607-617.
DOI: 10.1002/ccd.20727
Google Scholar
[7]
R. Waksman, R. Erbel, C.D. Mario, J. Bartunek, et al. Early- and Long-Term Intravascular Ultrasound and Angiographic Findings After Bioabsorbable Magnesium Stent Implantation in Human Coronary Arteries. J Am Coll Cardiol Intv. 2(2009) 312-320.
DOI: 10.1016/j.jcin.2008.09.015
Google Scholar
[8]
L.L. Rokhlin, T.V. Dobatkina I.F. Tarytina, V.N. Timofeev, et al. Peculiarities of the phase relations in Mgrich alloys of the Mg-Y-Nd system, Journal of Alloys and Compounds. 367 (2004)17-19.
DOI: 10.1016/j.jallcom.2003.08.004
Google Scholar
[9]
M.M. Avedesian, H. Baker (Eds. ), ASM Specialty Handbook, Magnesium and Magnesium Alloys, ASM International, The Materials Information Society, Ohio, 1999: 16-17.
Google Scholar
[10]
X.N. Gu , W.R. Zhou , Y.F. Zheng , Y. Cheng , et al. Corrosion fatigue behaviors of two biomedical Mg alloys–AZ91D and WE43– In simulated body fluid. Acta Biomaterial. 6(2010) 4605-4613.
DOI: 10.1016/j.actbio.2010.07.026
Google Scholar
[11]
H. Kalb, A. Rzany, B. Hensel . Impact of microgalvanic corrosion on the degradation morphology of WE43 and pure magnesium under exposure to simulated body fluid. Corrosion Science. 57(2012)122-130.
DOI: 10.1016/j.corsci.2011.12.026
Google Scholar
[12]
R. Zeng , W. Dietzel , F. Witte ,N. Hort , C. Blawert , Progress and challenge for magnesium alloys as biomaterials, Advanced Engineering Materials. 10(2008): B3-B14.
DOI: 10.1002/adem.200800035
Google Scholar
[13]
R. Arrabal , E. Matykina , F. Viejo , P. Skeldon, G.E. Thompson. Corrosion resistance of WE43 and AZ91D magnesium alloys with phosphate PEO coatings. Corrosion Science. 50( 2008)1744-1752.
DOI: 10.1016/j.corsci.2008.03.002
Google Scholar
[14]
C.D. Mario,P. Barlis, J. Tanigawa. Coronary bioabsorbable magnesium stent: 15- month intravascular ultrasound and optical coherence tomography findings. Eur. Heart J. 28( 2007)2319-2319.
DOI: 10.1093/eurheartj/ehm119
Google Scholar
[15]
A. Loos,R. Rohde, A. Haveich, S. Barlach. In vitro and in vivo biocompatibility testing of absorbable metal stents. Macromol Symp. 253(2007)103-108.
DOI: 10.1002/masy.200750715
Google Scholar
[16]
R. Rettig , S. Virtanen , Composition of corrosion layers on a magnesium rare-earth alloy in simulated body fluids, J Biomed Mater Res Part A. 88(2008) 359-369.
DOI: 10.1002/jbm.a.31887
Google Scholar
[17]
C. Antion, P. Donnadieu, F. Perrard, A. Deschamps, et al. Hardening precipitati-on in a Mg-4Y-3RE alloy, Acta Mater. 51( 2003) 5335-5348.
DOI: 10.1016/s1359-6454(03)00391-4
Google Scholar
[18]
T. Rzychoń, A. Kielbus, Microstructure of WE43 casting magnesium alloy, Journal of Achievements in Materials and Manufacturing Engineering. 21(2007)31-34.
Google Scholar
[19]
M. Joner, G. Nakazawa, A.V. Finn, S.C. Quee, et al. Endothelial cell recovery between comparator polymer-based drug-eluting stents. J Am Coll Cardiol. 52(2008) 333-342.
DOI: 10.1016/j.jacc.2008.04.030
Google Scholar
[20]
X.Q. Chen, Q.S. Yin, Y. Zhang, H. Xia, et al. Sensitization test of magnalium a the maximal dosage, Journal of Clinical Rehabilitative Tissue Engineering Research. 14(2010)2899-2902.
Google Scholar
[21]
X.N. Gu, Y.F. Zheng, Y. Cheng, S. P Zhong, T.F. Xi, In vitro corrosion and biocompatibility of binary magnesium alloys, Biomaterials. 30(2009)484-498.
DOI: 10.1016/j.biomaterials.2008.10.021
Google Scholar
[22]
M. Haude, R. Erbel, P. Erne, S. Verheye, et al. Safety and performance of the drug-eluting absorbable metal scaff old (DREAMS) in patients with de-novo coronary lesions: 12 month results of the prospective, multicentre, first-in-man BIOSOLVE-I trial. Lancet. 381(2013).
DOI: 10.1016/s0140-6736(12)61765-6
Google Scholar